Nuclear medicine imaging.

Currently, nuclear medicine imaging provides both functional/molecular and structural information, derived from a combination of different scientific techniques in radiochemical/radiopharmaceutical labeling, imaging technology, and image reconstruction methodologies as well as a good understanding of physiology and molecular biology and a sound approach to clinical interpretation. Pitfalls in nuclear medicine imaging fall into the following three main categories: (1) radioisotope or radiotracer; (2) scanning techniques, procedure, or scanner hardware or software; and (3) clinical, relating to patient factors and interpretation of scans. Various pitfalls from each category are described. Reducing artifacts arising from these three categories is key to the correct performance and interpretation of nuclear medicine studies.

[1]  V. Ambrosini,et al.  Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. , 2008, Cancer treatment reviews.

[2]  Yuji Nakamoto,et al.  Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  B. Cheson,et al.  Positron-emission tomography and assessment of cancer therapy. , 2006, The New England journal of medicine.

[4]  Gary Cook,et al.  Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. , 2009, Seminars in nuclear medicine.

[5]  H. Biersack,et al.  PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  G. Karanikas,et al.  Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging? , 2012, European Radiology.

[7]  R. Coleman,et al.  Recommendations on the Use of 18F-FDG PET in Oncology , 2008, Journal of Nuclear Medicine.

[8]  R. Hustinx,et al.  PET scan imaging in oncology. , 2003, European journal of cancer.

[9]  H. Fukuda,et al.  Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  J. Thie.  Understanding the standardized uptake value, its methods, and implications for usage. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  W. Oyen,et al.  Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.

[12]  R. Wahl,et al.  Initial experience with oral contrast in PET/CT: phantom and clinical studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  F. Mannting,et al.  Artifactual 2-deoxy-2-[(18)F]fluoro-D-glucose localization surrounding metallic objects in a PET/CT scanner using CT-based attenuation correction. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[14]  K. Kang,et al.  Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  Mithat Gonen,et al.  Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  E. Ficaro,et al.  Equilibrium radionuclide angiocardiography , 2006, Journal of Nuclear Cardiology.

[17]  Janet F Eary,et al.  Nuclear medicine in cancer diagnosis , 1999, The Lancet.

[18]  Marc Kachelriess,et al.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  L. Mortelmans,et al.  131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  Cyrill Burger,et al.  Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  S. Kameoka,et al.  Value of PET/CT imaging for diagnosing pulmonary metastasis of colorectal cancer. , 2011, Hepato-Gastroenterology.

[22]  Valentino Bettinardi,et al.  Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions , 2012, European Journal of Nuclear Medicine and Molecular Imaging.